These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3155500)

  • 41. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term oral enoximone therapy in chronic cardiac failure.
    Maskin CS; Weber KT; Janicki JS
    Am J Cardiol; 1987 Aug; 60(5):63C-67C. PubMed ID: 2956871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute hemodynamic effects of MDL 19205 in mild congestive heart failure.
    Cottier C; Follath F; Kiowski W; Pfisterer M; Emmenegger H; Burkart F
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):209-12. PubMed ID: 2436000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
    N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral hydralazine therapy for chronic refractory heart failure.
    Chatterjee K; Parmley WW; Massie B; Greenberg B; Werner J; Klausner S; Norman A
    Circulation; 1976 Dec; 54(6):879-83. PubMed ID: 825327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS; Forman R; Klein NA; Sonnenblick EH; LeJemtel TH
    Am J Med; 1982 Jan; 72(1):113-8. PubMed ID: 7058816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
    Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
    Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G; Butzer F; Dieterich HA; Heinrich F
    Am J Cardiol; 1987 Aug; 60(5):72C-74C. PubMed ID: 2956873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of long-term oral levodopa therapy in chronic congestive heart failure.
    Hasenfuss G; Kasper W; Meinertz T; Busch W; Lehmann M; Krause T; Hofmann T; Revenaugh M; Holubarsch C; Just H
    Klin Wochenschr; 1987 Nov; 65(22):1087-94. PubMed ID: 3121909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.
    Massie B; Ports T; Chatterjee K; Parmley W; Ostland J; O'Young J; Haughom F
    Circulation; 1981 Feb; 63(2):269-78. PubMed ID: 6778625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.
    Jafri SM; Burlew BS; Goldberg AD; Rogers A; Goldstein S
    Am J Cardiol; 1986 Feb; 57(4):254-9. PubMed ID: 3511661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinico-pharmacologic aspects of therapy with enoximone].
    Trenk D; Jähnchen E
    Z Kardiol; 1994; 83 Suppl 2():7-14. PubMed ID: 8091828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Long-term therapy of chronic cardiac insufficiency using enoximone].
    Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.